Five-year survival outcomes with durvalumab after chemoradiotherapy in unresectable stage III NSCLC: An update from the PACIFIC trial.


Spigel D. R., Faivre-Finn C., Gray J. E., Vicente D., Planchard D., Paz-Ares L. G., ...Daha Fazla

JOURNAL OF CLINICAL ONCOLOGY, cilt.39, sa.15, 2021 (SCI-Expanded, Scopus) identifier

  • Yayın Türü: Makale / Özet
  • Cilt numarası: 39 Sayı: 15
  • Basım Tarihi: 2021
  • Doi Numarası: 10.1200/jco.2021.39.15_suppl.8511
  • Dergi Adı: JOURNAL OF CLINICAL ONCOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, PASCAL, CAB Abstracts, CINAHL, EMBASE, Gender Studies Database, International Pharmaceutical Abstracts, MEDLINE, Veterinary Science Database
  • İstanbul Üniversitesi-Cerrahpaşa Adresli: Hayır